🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationEndotoxin testing in compounded injectables — LAL vs rFC methods Page 2

Endotoxin testing in compounded injectables — LAL vs rFC methods

LabKate Sat, Jun 6, 2026 at 12:43 AM 17 replies 423 viewsPage 2 of 4
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Jun 6, 2026 at 3:52 AM#6
rFC = Recombinant Factor C Factor C is the specific protein in the horseshoe crab's clotting cascade that initially recognizes and binds endotoxin. Scientists have cloned the gene for Factor C and produced it in insect cells (recombinant DNA technology). How rFC works: - Recombinant Factor C is mixed with the sample - If endotoxin is present, it activates Factor C - Activated Factor C cleaves a fluorogenic substrate - The resulting fluorescence is measured — intensity proportional to endotoxin concentration - No horseshoe crab blood needed rFC advantages: 1. No animal harvesting required — environmentally sustainable 2. Consistent lot-to-lot performance (recombinant = manufactured uniformly) 3. Less interference from beta-glucans (a common false-positive trigger in LAL) 4. Faster in some implementations 5. Supply chain is more stable and scalable rFC limitations: 1. Only detects endotoxin via the Factor C pathway. LAL has multiple recognition factors and may detect some non-LPS pyrogenic substances that rFC would miss. (Whether this is a limitation or an advantage depends on perspective — less false positives, but potentially less comprehensive.) 2. Regulatory acceptance: The USP added rFC as a valid alternative method in USP <85> (Bacterial Endotoxins Test) with the 2019 supplement. The FDA has accepted it. But some conservative QA departments still prefer LAL. 3. Currently costs slightly more per test than LAL, though the gap is closing. Bottom line for you as a patient: Whether your CoA says "LAL method" or "rFC method," both are valid, USP-accepted methods for endotoxin testing. The fact that your pharmacy IS testing for endotoxins at all and reporting the result on the CoA is the key positive signal. Many less rigorous operations don't test for endotoxins at all.
45 15hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 42 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jun 6, 2026 at 5:06 AM#7
Great explanation. A few practical additions: What to look for on your CoA regarding endotoxins: ✅ Good: "Endotoxin: <0.25 EU/mL (LAL gel-clot)" or "<5 EU/mL (rFC chromogenic)" ✅ Good: "Endotoxin: 0.08 EU/mL (LAL kinetic turbidimetric)" ✅ Good: "BET per USP <85>: Passes" ⚠️ Concerning: "Endotoxin: Tested" (no value reported) ⚠️ Concerning: No endotoxin line item on the CoA at all ❌ Bad: "Endotoxin: Not tested" or no CoA available The specific EU/mL limit depends on the product, route, and dose. For subcutaneous injections like semaglutide, the USP-derived limit is calculated as: Endotoxin limit = 5 EU/kg ÷ Maximum dose volume (mL/kg/hour) For a typical sema dose of 0.1-0.5 mL, the calculated limit would be very generous — well above the <0.25 EU/mL on your CoA. Your product passes with a wide margin.
Last edited: Jun 6, 2026 at 7:06 AM
44 14Dr.PathRoch, mona_PHX, andrew_nyc and 41 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jun 6, 2026 at 6:21 AM#8
This thread is exactly what I was hoping for. One more question: is there a test for non-endotoxin pyrogens? Like, can something other than endotoxins cause a fever response from an injection?
43 13Dr.EndoIndy, tom_AK, josh_phd_bmore and 40 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Jun 6, 2026 at 7:35 AM#9
Great question. Yes, there are non-endotoxin pyrogens: Non-endotoxin pyrogens include: - Gram-positive bacterial components (lipoteichoic acid, peptidoglycan) - Fungal components (beta-glucans) - Viral particles - Some chemicals and drug degradation products Neither LAL nor rFC detect these — they're specific to gram-negative endotoxin. The Monocyte Activation Test (MAT): This is a newer test that detects ALL pyrogens, not just endotoxin. It works by exposing human monocytes (immune cells) to the sample and measuring the cytokine response (IL-6 or IL-1β). If the monocytes react, something pyrogenic is present — regardless of whether it's endotoxin, gram-positive components, or anything else. MAT is described in USP <151> (Pyrogen Test alternatives) and is accepted by the European Pharmacopoeia. It's gaining adoption but is not yet widely used in US compounding pharmacies. For practical purposes as a patient, the combination of: - Sterility testing (USP <71>) — catches viable microorganisms - Endotoxin testing (USP <85>) — catches the most common and dangerous pyrogen - Visual inspection and particulate testing — catches visible contamination ...provides a robust quality screen. MAT would add another layer but is not standard for compounded preparations. If your pharmacy tests for sterility AND endotoxins, they're doing more than many.
42 12NurseLeah_Nash, gary_naperville, sean_dublin and 39 others
Reply Quote Save Share Report
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jun 6, 2026 at 1:33 PM#10
Excellent. I feel like I actually understand my CoA now. The fact that my pharmacy tests for endotoxins AND provides the result on the CoA gives me confidence. Sharing this thread with my support group — most people I talk to have never even heard of endotoxin testing and have no idea what to look for on a CoA. Education is power.
26 24DeniseRN_TPA, SandraNC_45, Dr.EndoIndy and 23 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register